美国 · SEC FORM 4
SI-BONE, Inc.
SIBN · Nasdaq · CIK 0001459839 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
55 同一窗口内观察到的 Form 4 交易行
44 sales · 11 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 3 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot.—
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 5,116,241
- 上期报告
- 5,914,143
- 日均成交量
- 591,117
- 回补天数
- 8.7
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
本地 Form 4 历史中没有合资格的代码 P 股票买入。
Form 4 申报证据
127 transaction lines in the latest 365-day window; 790 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-12 | FRANCIS LAURA | 卖出 (S) | Common Stock | 38,006 | USD 20.05 | USD 762,013 | SEC 申报 ↗ |
| 2026-10-05 | Maheshwari Anshul | 卖出 (S) | Common Stock | 1,731 | USD 19.50 | USD 33,754 | SEC 申报 ↗ |
| 2026-10-02 | PISETSKY MICHAEL A. | 卖出 (S) | Common Stock | 3,133 | USD 18.17 | USD 56,918 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-12 | FRANCIS LAURA | 卖出 (S) | Common Stock | 38,006 | USD 20.05 | USD 762,013 | SEC 申报 ↗ |
| 2026-10-05 | Maheshwari Anshul | 卖出 (S) | Common Stock | 1,731 | USD 19.50 | USD 33,754 | SEC 申报 ↗ |
| 2026-10-02 | PISETSKY MICHAEL A. | 卖出 (S) | Common Stock | 3,133 | USD 18.17 | USD 56,918 | SEC 申报 ↗ |
| 2026-10-02 | Maheshwari Anshul | 卖出 (S) | Common Stock | 3,318 | USD 18.18 | USD 60,325 | SEC 申报 ↗ |
| 2026-10-01 | DUNN JEFFREY W | 卖出 (S) | Common Stock | 20,000 | USD 18.47 | USD 369,400 | SEC 申报 ↗ |
| 2026-10-01 | DUNN JEFFREY W | 期权行权／转换 (M) | Common Stock | 20,000 | USD 4.68 | USD 93,600 | SEC 申报 ↗ |
| 2026-09-01 | DUNN JEFFREY W | 卖出 (S) | Common Stock | 20,000 | USD 18.91 | USD 378,200 | SEC 申报 ↗ |
| 2026-09-01 | DUNN JEFFREY W | 期权行权／转换 (M) | Common Stock | 20,000 | USD 4.68 | USD 93,600 | SEC 申报 ↗ |
| 2026-08-24 | Maheshwari Anshul | 卖出 (S) | Common Stock | 11,636 | USD 20.11 | USD 234,000 | SEC 申报 ↗ |
| 2026-08-24 | FRANCIS LAURA | 卖出 (S) | Common Stock | 25,972 | USD 20.12 | USD 522,557 | SEC 申报 ↗ |
| 2026-08-21 | Maheshwari Anshul | 卖出 (S) | Common Stock | 11,228 | USD 20.02 | USD 224,785 | SEC 申报 ↗ |
| 2026-08-21 | FRANCIS LAURA | 卖出 (S) | Common Stock | 3,923 | USD 20.02 | USD 78,538 | SEC 申报 ↗ |
| 2026-08-20 | FRANCIS LAURA | 卖出 (S) | Common Stock | 51,884 | USD 19.46 | USD 1,009,663 | SEC 申报 ↗ |
| 2026-08-19 | Maheshwari Anshul | 卖出 (S) | Common Stock | 5,747 | USD 19.55 | USD 112,354 | SEC 申报 ↗ |
| 2026-08-17 | PISETSKY MICHAEL A. | 卖出 (S) | Common Stock | 3,725 | USD 18.64 | USD 69,416 | SEC 申报 ↗ |
| 2026-08-17 | Maheshwari Anshul | 卖出 (S) | Common Stock | 4,665 | USD 18.65 | USD 87,011 | SEC 申报 ↗ |
| 2026-08-17 | FRANCIS LAURA | 卖出 (S) | Common Stock | 14,956 | USD 18.66 | USD 279,064 | SEC 申报 ↗ |
| 2026-08-03 | DUNN JEFFREY W | 卖出 (S) | Common Stock | 20,000 | USD 18.46 | USD 369,200 | SEC 申报 ↗ |
| 2026-08-03 | DUNN JEFFREY W | 期权行权／转换 (M) | Common Stock | 20,000 | USD 4.68 | USD 93,600 | SEC 申报 ↗ |
| 2026-07-02 | PISETSKY MICHAEL A. | 卖出 (S) | Common Stock | 3,134 | USD 16.71 | USD 52,382 | SEC 申报 ↗ |
| 2026-07-02 | Maheshwari Anshul | 卖出 (S) | Common Stock | 3,317 | USD 16.77 | USD 55,616 | SEC 申报 ↗ |
| 2026-06-05 | DUNN JEFFREY W | 卖出 (S) | Common Stock | 3,575 | USD 15.25 | USD 54,519 | SEC 申报 ↗ |
| 2026-06-04 | HILLEMAN JERYL L | 奖励／授予 (A) | Common stock | 10,957 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | West Thomas A. | 奖励／授予 (A) | Common Stock | 10,957 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | Nishimura Mika | 奖励／授予 (A) | Common Stock | 10,957 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | Freund John Gordon | 奖励／授予 (A) | Common Stock | 10,957 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | Davis Timothy E JR | 奖励／授予 (A) | Common Stock | 10,957 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | DUNN JEFFREY W | 奖励／授予 (A) | Common Stock | 10,957 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-29 | Davis Timothy E JR | 卖出 (S) | Common Stock | 3,500 | USD 14.14 | USD 49,490 | SEC 申报 ↗ |
| 2026-05-28 | Davis Timothy E JR | 卖出 (S) | Common Stock | 3,780 | USD 14.47 | USD 54,697 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | SIBN |
| CIK | 0001459839 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 790 transaction lines from 2020-01-03 to 2026-10-12 0 P purchase lines · 622 S sale lines · 168 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.